Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Kronenberg

Showing results (11-20 of 450) with videos related to

Pageof 45
Sort By:
Atherosclerosis|May 23, 2022
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?Florian Kronenberg
Current Opinion in Lipidology|November 22, 2016
Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney functionFlorian Kronenberg
Journal of the American Society of Nephrology : JASN|February 24, 2018
HDL in CKD-The Devil Is in the DetailFlorian Kronenberg
Circulation. Cardiovascular Genetics|August 19, 2010
Association of bilirubin with cardiovascular outcomes: more hype than substance?Florian Kronenberg
Atherosclerosis|March 12, 2014
Lipoprotein(a) in various conditions: to keep a sense of proportionsFlorian Kronenberg
Current Atherosclerosis Reports|January 22, 2024
Lipoprotein(a): from Causality to TreatmentFlorian Kronenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2011
APOL1 variants and kidney disease. There is no such thing as a free lunchFlorian Kronenberg
European Heart Journal|September 5, 2025
Lipoprotein(a) and forms of dementia: an area of complexityFlorian Kronenberg
Atherosclerosis|July 23, 2019
Therapeutic lowering of lipoprotein(a): How much is enough?Florian Kronenberg
Circulation|February 12, 2014
Lipoprotein(a): there's life in the old dog yetFlorian Kronenberg
Pageof 45

Showing results (11-20 of 450) with videos related to

Sort By:
Pageof 45
Atherosclerosis|May 23, 2022
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?Florian Kronenberg
Current Opinion in Lipidology|November 22, 2016
Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney functionFlorian Kronenberg
Journal of the American Society of Nephrology : JASN|February 24, 2018
HDL in CKD-The Devil Is in the DetailFlorian Kronenberg
Circulation. Cardiovascular Genetics|August 19, 2010
Association of bilirubin with cardiovascular outcomes: more hype than substance?Florian Kronenberg
Atherosclerosis|March 12, 2014
Lipoprotein(a) in various conditions: to keep a sense of proportionsFlorian Kronenberg
Current Atherosclerosis Reports|January 22, 2024
Lipoprotein(a): from Causality to TreatmentFlorian Kronenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2011
APOL1 variants and kidney disease. There is no such thing as a free lunchFlorian Kronenberg
European Heart Journal|September 5, 2025
Lipoprotein(a) and forms of dementia: an area of complexityFlorian Kronenberg
Atherosclerosis|July 23, 2019
Therapeutic lowering of lipoprotein(a): How much is enough?Florian Kronenberg
Circulation|February 12, 2014
Lipoprotein(a): there's life in the old dog yetFlorian Kronenberg
Pageof 45